Yasunori Matsumoto Selected Research

Metformin (Glucophage)

1/2022	Metformin-Induced Heat Shock Protein Family A Member 6 Is a Promising Biomarker of Esophageal Squamous Cell Carcinoma.
11/2018	The Antitumor Effects of Metformin on Gastric Cancer In Vitro and on Peritoneal Metastasis.
4/2018	Antitumor effects of metformin are a result of inhibiting nuclear factor kappa B nuclear translocation in esophageal squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasunori Matsumoto Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 10/2014
12	Esophageal Squamous Cell Carcinoma 03/2022 - 01/2016
4	Neoplasm Metastasis (Metastasis) 11/2018 - 12/2014
3	Pancreatic Neoplasms (Pancreatic Cancer) 04/2019 - 10/2014
2	Stomach Neoplasms (Stomach Cancer) 06/2022 - 11/2018
2	Esophageal Neoplasms (Esophageal Cancer) 10/2021 - 07/2019
1	Postoperative Hemorrhage 06/2022
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2022
1	Hemorrhage 01/2022
1	Lymphatic Metastasis 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Pneumonia (Pneumonitis) 10/2021
1	Melanoma (Melanoma, Malignant) 08/2020
1	Carcinogenesis 07/2019
1	Inflammation (Inflammations) 04/2018
1	Type 2 Diabetes Mellitus (MODY) 04/2018
1	Ovarian Neoplasms (Ovarian Cancer) 05/2015
1	Fibrosarcoma 01/2015
1	Sarcoma (Soft Tissue Sarcoma) 12/2014
1	Osteosarcoma (Osteogenic Sarcoma) 12/2014
1	Prostatic Neoplasms (Prostate Cancer) 11/2014
1	Hyperplasia 09/2003
1	Pathologic Constriction (Stenosis) 09/2003
1	Atrial Fibrillation 09/2003
1	Atrial Remodeling 07/2002

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 03/2022 - 11/2016
4	Green Fluorescent ProteinsIBA 04/2015 - 10/2014
3	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 04/2018
3	Proteins (Proteins, Gene)FDA Link 11/2018 - 10/2014
2	Histones (Histone)IBA 07/2019 - 01/2016
2	ChromatinIBA 07/2019 - 10/2014
2	Histone DemethylasesIBA 07/2019 - 01/2016
2	Pharmaceutical PreparationsIBA 11/2018 - 01/2015
2	Indicators and Reagents (Reagents)IBA 01/2015 - 09/2003
1	Sirtuin 1IBA 03/2022
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2022
1	Biological ProductsIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	CateninsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 08/2020
1	NivolumabIBA 08/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2019
1	130-nm albumin-bound paclitaxelIBA 04/2019
1	Gemcitabine FDA Link 04/2019
1	Phosphotransferases (Kinase)IBA 11/2018
1	Glucose (Dextrose)FDA LinkGeneric 11/2018
1	Transcription Factors (Transcription Factor)IBA 04/2018
1	NF-kappa B (NF-kB)IBA 04/2018
1	LigandsIBA 01/2018
1	fos-related antigen 1IBA 10/2017
1	GTP-Binding Proteins (G-Protein)IBA 11/2016
1	MicroRNAs (MicroRNA)IBA 11/2016
1	Zoledronic Acid (Zometa)FDA Link 10/2015
1	Red Fluorescent ProteinIBA 12/2014
1	Carrier Proteins (Binding Protein)IBA 10/2014
1	Phenobarbital (Luminal)FDA Link 09/2003
1	Endothelin A ReceptorIBA 07/2002

Therapy/Procedure

3	Therapeutics 04/2019 - 12/2014
2	Drug Therapy (Chemotherapy) 04/2019 - 12/2014
2	Aftercare (After-Treatment) 01/2015 - 11/2014
1	Gastrectomy 06/2022
1	Length of Stay 06/2022
1	Pancreaticoduodenectomy 01/2022
1	Esophagectomy 10/2021
1	Thoracotomy 10/2021
1	Neoadjuvant Therapy 04/2019
1	Intraperitoneal Injections 05/2015
1	Catheter Ablation 09/2003